- Gatsbie
- Investor lists
- AI
- AI and Biotech
- Asia-Pacific
AI and Biotech investors in Asia-Pacific
16 funds · Updated
Gatsbie lists 16 AI and Biotech investors headquartered in Asia-Pacific (as of 2026-11-18).
Each one names both artificial intelligence and biotech & life sciences in its investment focus.
Most are based in India (8), Australia (2) and China (2); the most common stages are Seed (12), Series A (12) and Series B (9); the most common kinds of capital are Venture equity (13), Growth equity (5) and Debt (3).
Which AI and Biotech investors are based in Asia-Pacific?
Gatsbie lists 16 AI and Biotech investors headquartered in Asia-Pacific (as of 2026-11-18). Most are in India (8), Australia (2) and China (2). They include Ideaspring Capital (Bengaluru), Ankur Capital (Mumbai), GRC SinoGreen Fund (Cayman Islands), IMM Investment, Corp. (Seoul), NIIF | India's premier sovereign-anchored alternative assets manager (Mumbai) and Speciale Invest (Chennai). Most deals on record in the last 24 months: Ideaspring Capital (1 deal).
Which family offices invest in AI and Biotech in Asia-Pacific?
2 of the 16 AI and Biotech investors on Gatsbie are family offices, including ERAGON FAMILY OFFICE and Narotam Sekhsaria Family Office.
Upload your deck to see which of these fit your startup, with a written reason for each.
16 funds
Most active first: deals in the last 24 months, then portfolio companies on record.
| # | Fund | HQ | Stages | Partner emails |
|---|---|---|---|---|
| 1 | Ideaspring Capital | Bengaluru | Pre-Seed–Series B | 7 |
| 2 | Ankur Capital | Mumbai | Pre-Seed–Series A | 12 |
| 3 | GRC SinoGreen Fund | Cayman Islands | Series C+ | 11 |
| 4 | IMM Investment, Corp. | Seoul | Seed–Series C+ | 10 |
| 5 | NIIF | India's premier sovereign-anchored alternative assets manager | Mumbai | Growth | 6 |
| 6 | Speciale Invest | Chennai | Pre-Seed, Seed | 16 |
| 7 | Verge Healthtech Fund | Singapore | Pre-Seed–Series A | 9 |
| 8 | Unicorn India Ventures | Mumbai | Seed, Series A | 1 |
| 9 | ERAGON FAMILY OFFICE | Mumbai | Seed–Series B, Growth | 1 |
| 10 | Exfinity Venture Partners | Bangalore | Seed–Series C+ | 11 |
| 11 | HMC Capital | Santiago | Seed–Series C+ | 1 |
| 12 | Ecliptic Venture Capital | Auckland | Pre-Seed–Series B | 3 |
| 13 | Narotam Sekhsaria Family Office | Mumbai | Mature | 6 |
| 14 | Ceyuan Ventures | Hong Kong | Pre-Seed–Series B | 17 |
| 15 | Main Sequence | Sydney | Pre-Seed–Series B | 15 |
| 16 | The Hina Group | San Francisco | Series A, Series B, Growth, Mature | 9 |
Other sector pairs
AI and Biotech investors elsewhere
Counted by where each fund is headquartered, from public sources, as of 2026-11-18. Only funds naming both sectors are listed.
